“Global Contrast Media Market by Manufacturers, Countries, Type and Application, Forecast to 2023 Report “Provides In-Depth Analysis Of Parent Market Trends, Macro-Economic Indicators And Governing Factors Along With Market Attractiveness As Per Segments. The Global Contrast Media Market Research Report is expected to grow at a CAGR of ~6.3% during forecasted period-(2017-2023).
Market Research Future published new report, titled “Contrast Media Market -Research Report: Global Forecast to 2023”.
Contrast Media Global Market – Overview
Contrast Media is a substances which is used to enhance the contrast of fluids in the body during medical imaging. It is basically used to enhance the visibility of blood vessels and GI tract. Recently, the Contrast Media Market has seen many headways in terms of products and their approvals in order to address the augmented demand and meet the expectations of patients and radiologists across the globe. These advancements have also prompted the enhanced utilization of most of the existing Contrast Media agents while presenting the advent agents. The Global Contrast Media Market is growing with the rapid pace; mainly due to the advancement in medical imaging technology and techniques, rising prevalence of various diseases like GIT, Cancer, Cardiac diseases, coupled with the growing number of cancer population.
Acknowledging its growing adoption Contrast Media and the exponential traction the Contrast Media market is gaining currently, the Market Research Future, recently published an eloquent study report – The global Contrast Media Market. Letting out the development policies and plans of industry players analysing the manufacturing processes along with the cost structures. The Analysis indicates that the Market is booming and estimated to gain further prominence over the forecast period. Further MRFR asserts that the Market will demonstrate a massive growth by 2023, phenomenally superseding its previous growth records in terms of value with a striking 6.3% of a CAGR during the anticipated period (2017 – 2023).
The Contrast Media Market is predominantly driven by the introduction of innovative techniques and development in medical imaging techniques. Furthermore, approvals for contrast agents and increase in the number of public and private diagnostic centers to improve diagnostic imaging services are fostering the demand of various diagnostic imaging modalities. Strong product pipelines of the market players and the increasing research activities working towards the applications of various contrast agents, are paving the ways for the market growth potential. While risk of side effects and adverse effects of the contrast media may hinder the growth of the market; advantages offered by the technological innovations are expected to provide impetus to the Contrast Media Market growth. Recent Trends observed during the analysis are syringe less contrast media injectors that supports minimized contrast media wastage and software advancements that brings ease in the use of the devices.
The risk of AKI with CABG versus PCI is declining, a possible explanation is increased use of off-pump CABG procedures, which might be safer for the kidneys. Another possibility is that surgeons performing CABG procedures with less contrast media, which is associated with kidney injury. Echocardiography experts say up to 20 percent of all resting echocardiography studies, and up to 30 percent of those conducted in critical care patients, can result in suboptimal echocardiograms. A suboptimal image is one in which two or more contiguous left ventricular segments in any of the three apical views cannot be visualized. The use of contrast in suboptimal echocardiograms can improve the diagnostic quality of these otherwise suboptimal exams
Major Players: GE Healthcare (US), Daiichi (Japan), Bayer Healthcare Pharmaceuticals (Germany), AMAG Pharmaceuticals (US), NanoScan Imaging (US), Medrad Inc. (US), Targeson (US), Guerbet (Japan), Bracco Diagnostic Inc. (Italy), Guerbet Group (France), Covidien (Ireland), Lantheus Medical Imaging (U.S.), ), Bracco Imaging S.p.A. (Italy), Subhra Pharma Private Limited (India), nanoPET Pharma GmbH (Germany), CMC Contrast AB (Sweden), and Mallinckrodt Pharmaceuticals (UK) are some of the prominent players at the forefront of competition in the Global Contrast Media Market and are profiled in MRFR Analysis.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/1284 .
Contrast Media Market – Competitive Analysis
Various dynamic and diversified international organizations, domestic organizations and as well as new entrants form a competitive landscape. Market leaders are innovating continuously and increasingly seeking market expansion through various strategic mergers and acquisitions, innovation, increasing investments in research and development and cost-effective product portfolio.
Increasing investments transpired in to R&D activities are expected to attract several new entrants which in turn will intensify the competition in the market.
Industry, Innovation & Related News
25 November 2017 – Guerbet (France) launched Contrast & Care, a contrast media injection management solution for radiology centers. The launch of the solution is part of the strategy of Guerbet to develop a portfolio of digital solutions to optimize the care and management of patients by healthcare professionals.
Contrast Media Market – Segmentations
Global Contrast Media Market is segmented in to 5 Key dynamics for an easy grasp and enhanced understanding.
Segmentation by Type: Comprises Intravenous Contrast Materials, Iodine-based.
Segmentation by Procedure: Comprises X-ray, Computed Tomography, Magnetic Resonance Imaging, and Ultrasound among others.
Segmentation by Route of Administration: Comprises Rectal, Oral, And Injectable.
Segmentation by Application: Comprises Cardiovascular Disorders, Oncology, and Nephrological Disorders among others.
Segmentation by Region: Comprises – Geographical Regions
Contrast Media Market – Regional Analysis
On regional basis, contrast media market is dominated by North America which is followed by Europe. Presence of major players in North America and Europe and increasing prevalence of GI disease are the major factor for the growth of the market in this region. Asia Pacific is the third largest market and the fastest growing contrast media market. Rising awareness regarding product benefits among consumers and a huge population base in this region is the major factor for the growth of the market.
GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/1284 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312